Silent Crohn’s disease may have little or no symptoms. It's important to monitor disease activity and treat the condition to ...
Among women with Crohn disease and prior perianal surgery, vaginal delivery was not associated with more adverse maternal outcomes than c-section.
The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL)-23 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback